Correction of endotoxin-induced endothelial dysfunction by recombinant erythropoetin and inhibitors of HMG-Co-A-reductase

Correction of endotoxin-induced endothelial dysfunction by recombinant erythropoetin and inhibitors of HMG-Co-A-reductase

Using the combined use of recombinant erythropoietin «Darbopoetin alpha» (500 mcg / kg) with simvastatin, atorvastatin, rosuvastatin and rosuvastatin nanopartikulirovanny on background modeling sepsis-induced disease, the introduction of strain 603 Staphylococcusaureus shows endotelio- and cardiopro...

Full description

Bibliographic Details
Main Authors: T. A. Denisyuk, M. V. Pokrovsky, T. G. Pokrovskaya, M. V. Korokin, O. S. Gudyrev, K. M. Reznikov, S. V. Povetkin, A. A. Stepchenko
Format: Article
Language:Russian
Published: Ministry of Healthcare of the Russian Federation. “Kuban State Medical University” 2015-12-01
Series:Кубанский научный медицинский вестник
Subjects:
эндотелиальная дисфункция
рекомбинантный эритропоэтин
статины
эндотоксин
endothelial dysfunction
recombinant erythropoietin
statin
endotoxin
Online Access:https://ksma.elpub.ru/jour/article/view/417

Internet

https://ksma.elpub.ru/jour/article/view/417

Similar Items